MediPharm Labs Corp. (OTCMKTS:MEDIF) Sees Significant Decrease in Short Interest

MediPharm Labs Corp. (OTCMKTS:MEDIF) saw a large decline in short interest in May. As of May 15th, there was short interest totaling 34,298 shares, a decline of 78.5% from the April 30th total of 159,517 shares. Based on an average daily volume of 188,139 shares, the days-to-cover ratio is presently 0.2 days.

MediPharm Labs Price Performance

Shares of OTCMKTS MEDIF traded up $0.00 during trading on Friday, hitting $0.06. 18,776 shares of the company were exchanged, compared to its average volume of 88,020. MediPharm Labs has a 1 year low of $0.04 and a 1 year high of $0.08. The firm’s fifty day moving average price is $0.05 and its 200 day moving average price is $0.05.

About MediPharm Labs

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.